Pay in 4 interest-free payments of $80.50 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0
Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells
Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2
DLK1 (Protein delta homolog 1
MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) to treat several different cancer types
Z-VAD-FMK Pack Size:1 mg selective and orally bioavailable Bcl-2Z VAD FMK (Z VAD(OH) FMK) is a well know pan caspase inhibitor, which does not inhibit ubiquitin carboxy terminal hydrolase L1 (UCHL1) activity even at concentrations as high as 440 M.